annual FCF:
$3.54B-$128.70M(-3.51%)Summary
- As of today (June 2, 2025), REGN annual free cash flow is $3.54 billion, with the most recent change of -$128.70 million (-3.51%) on December 31, 2024.
- During the last 3 years, REGN annual FCF has fallen by -$2.99 billion (-45.80%).
- REGN annual FCF is now -45.80% below its all-time high of $6.53 billion, reached on December 31, 2021.
Performance
REGN Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$773.60M-$222.20M(-22.31%)Summary
- As of today (June 2, 2025), REGN quarterly free cash flow is $773.60 million, with the most recent change of -$222.20 million (-22.31%) on March 31, 2025.
- Over the past year, REGN quarterly FCF has dropped by -$577.10 million (-42.73%).
- REGN quarterly FCF is now -76.42% below its all-time high of $3.28 billion, reached on September 30, 2021.
Performance
REGN quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$2.96B-$577.10M(-16.31%)Summary
- As of today (June 2, 2025), REGN TTM free cash flow is $2.96 billion, with the most recent change of -$577.10 million (-16.31%) on March 31, 2025.
- Over the past year, REGN TTM FCF has dropped by -$968.00 million (-24.63%).
- REGN TTM FCF is now -62.68% below its all-time high of $7.94 billion, reached on March 31, 2022.
Performance
REGN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
REGN Free cash flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -3.5% | -42.7% | -24.6% |
3 y3 years | -45.8% | -60.5% | -62.7% |
5 y5 years | +76.9% | +46.5% | +73.7% |
REGN Free cash flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -45.8% | +4.2% | -60.5% | +275.7% | -62.7% | +17.2% |
5 y | 5-year | -45.8% | +76.9% | -76.4% | +275.7% | -62.7% | +87.2% |
alltime | all time | -45.8% | +1879.2% | -76.4% | +275.7% | -62.7% | +1066.1% |
REGN Free cash flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $773.60M(-22.3%) | $2.96B(-16.3%) |
Dec 2024 | $3.54B(-3.5%) | $995.80M(-5.1%) | $3.54B(+6.6%) |
Sep 2024 | - | $1.05B(+633.3%) | $3.32B(+4.2%) |
Jun 2024 | - | $143.10M(-89.4%) | $3.18B(-19.0%) |
Mar 2024 | - | $1.35B(+74.0%) | $3.93B(+7.1%) |
Dec 2023 | $3.67B(+7.9%) | $776.20M(-15.1%) | $3.67B(-15.9%) |
Sep 2023 | - | $914.40M(+2.9%) | $4.36B(+45.1%) |
Jun 2023 | - | $888.50M(-18.4%) | $3.00B(+18.9%) |
Mar 2023 | - | $1.09B(-25.8%) | $2.53B(-25.6%) |
Dec 2022 | $3.40B(-48.0%) | $1.47B(-433.3%) | $3.40B(-18.1%) |
Sep 2022 | - | -$440.40M(-207.2%) | $4.15B(-47.3%) |
Jun 2022 | - | $410.80M(-79.0%) | $7.87B(-0.8%) |
Mar 2022 | - | $1.96B(-11.6%) | $7.94B(+21.5%) |
Dec 2021 | $6.53B(+225.9%) | $2.22B(-32.4%) | $6.53B(+21.3%) |
Sep 2021 | - | $3.28B(+586.0%) | $5.38B(+217.8%) |
Jun 2021 | - | $478.20M(-13.6%) | $1.69B(-16.5%) |
Mar 2021 | - | $553.20M(-48.3%) | $2.03B(+1.3%) |
Dec 2020 | $2.00B(+0.2%) | $1.07B(-362.5%) | $2.00B(+26.6%) |
Sep 2020 | - | -$407.50M(-150.1%) | $1.58B(-34.8%) |
Jun 2020 | - | $813.50M(+54.1%) | $2.43B(+42.2%) |
Mar 2020 | - | $527.90M(-18.6%) | $1.71B(-14.7%) |
Dec 2019 | $2.00B(+10.4%) | $648.40M(+48.9%) | $2.00B(+0.3%) |
Sep 2019 | - | $435.60M(+364.9%) | $2.00B(+4.7%) |
Jun 2019 | - | $93.70M(-88.6%) | $1.91B(-9.0%) |
Mar 2019 | - | $822.70M(+27.9%) | $2.10B(+15.6%) |
Dec 2018 | $1.81B(+75.2%) | $643.30M(+85.5%) | $1.81B(+11.3%) |
Sep 2018 | - | $346.70M(+22.7%) | $1.63B(-0.5%) |
Jun 2018 | - | $282.60M(-47.6%) | $1.64B(+29.0%) |
Mar 2018 | - | $539.40M(+17.4%) | $1.27B(+22.6%) |
Dec 2017 | $1.03B(+6.2%) | $459.30M(+29.3%) | $1.03B(+26.9%) |
Sep 2017 | - | $355.18M(-515.8%) | $815.17M(-17.9%) |
Jun 2017 | - | -$85.42M(-128.0%) | $992.46M(-25.9%) |
Mar 2017 | - | $305.44M(+27.3%) | $1.34B(+37.4%) |
Dec 2016 | $974.00M(+49.2%) | $239.97M(-54.9%) | $974.00M(+16.2%) |
Sep 2016 | - | $532.47M(+104.3%) | $838.08M(-20.4%) |
Jun 2016 | - | $260.66M(-541.0%) | $1.05B(+30.0%) |
Mar 2016 | - | -$59.10M(-156.8%) | $809.63M(+24.0%) |
Dec 2015 | $652.85M(+55.7%) | $104.04M(-86.1%) | $652.85M(+3.7%) |
Sep 2015 | - | $746.75M(+4063.0%) | $629.44M(-2021.0%) |
Jun 2015 | - | $17.94M(-108.3%) | -$32.77M(-115.3%) |
Mar 2015 | - | -$215.89M(-367.7%) | $214.84M(-48.8%) |
Dec 2014 | $419.43M(-3.0%) | $80.63M(-4.6%) | $419.43M(-24.0%) |
Sep 2014 | - | $84.55M(-68.2%) | $551.55M(+4.5%) |
Jun 2014 | - | $265.54M(-2450.9%) | $527.76M(+48.3%) |
Mar 2014 | - | -$11.29M(-105.3%) | $355.93M(-17.7%) |
Dec 2013 | $432.27M(-448.7%) | $212.75M(+250.1%) | $432.27M(+45.3%) |
Sep 2013 | - | $60.76M(-35.2%) | $297.54M(+32.7%) |
Jun 2013 | - | $93.71M(+44.1%) | $224.15M(+472.0%) |
Mar 2013 | - | $65.05M(-16.6%) | $39.19M(-131.6%) |
Dec 2012 | -$123.95M(-37.7%) | $78.02M(-717.8%) | -$123.95M(-53.0%) |
Sep 2012 | - | -$12.63M(-86.2%) | -$263.58M(-14.0%) |
Jun 2012 | - | -$91.25M(-7.0%) | -$306.58M(+16.0%) |
Mar 2012 | - | -$98.10M(+59.2%) | -$264.25M(+32.9%) |
Dec 2011 | -$198.90M(>+9900.0%) | -$61.61M(+10.7%) | -$198.90M(-5.5%) |
Sep 2011 | - | -$55.63M(+13.7%) | -$210.41M(+1268.5%) |
Jun 2011 | - | -$48.91M(+49.4%) | -$15.38M(+1623.7%) |
Mar 2011 | - | -$32.75M(-55.2%) | -$892.00K(+91.0%) |
Dec 2010 | -$467.00K(-99.7%) | -$73.11M(-152.4%) | -$467.00K(-111.9%) |
Sep 2010 | - | $139.40M(-504.9%) | $3.93M(-102.3%) |
Jun 2010 | - | -$34.43M(+6.5%) | -$167.63M(+1.9%) |
Mar 2010 | - | -$32.32M(-53.0%) | -$164.57M(-2.9%) |
Dec 2009 | -$169.55M(+36.8%) | -$68.72M(+113.7%) | -$169.55M(+11.2%) |
Sep 2009 | - | -$32.15M(+2.5%) | -$152.41M(-10.9%) |
Jun 2009 | - | -$31.38M(-15.9%) | -$171.13M(+22.0%) |
Mar 2009 | - | -$37.30M(-27.7%) | -$140.30M(+13.2%) |
Dec 2008 | -$123.94M | -$51.58M(+1.4%) | -$123.94M(+284.0%) |
Sep 2008 | - | -$50.87M(+9234.7%) | -$32.28M(-1106.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2008 | - | -$545.00K(-97.4%) | $3.21M(-302.5%) |
Mar 2008 | - | -$20.94M(-152.2%) | -$1.58M(-117.7%) |
Dec 2007 | $8.93M(-56.0%) | $40.09M(-360.4%) | $8.93M(-57.4%) |
Sep 2007 | - | -$15.39M(+188.6%) | $20.93M(+0.3%) |
Jun 2007 | - | -$5.33M(-48.9%) | $20.88M(+301.7%) |
Mar 2007 | - | -$10.44M(-120.0%) | $5.20M(-74.4%) |
Dec 2006 | $20.26M(-157.5%) | $52.09M(-437.2%) | $20.26M(-138.9%) |
Sep 2006 | - | -$15.45M(-26.5%) | -$52.03M(-2.4%) |
Jun 2006 | - | -$21.02M(-553.7%) | -$53.30M(-14.6%) |
Mar 2006 | - | $4.63M(-122.9%) | -$62.40M(+77.0%) |
Dec 2005 | -$35.26M(+52.8%) | -$20.20M(+20.8%) | -$35.26M(+23.3%) |
Sep 2005 | - | -$16.71M(-44.5%) | -$28.59M(+60.8%) |
Jun 2005 | - | -$30.12M(-194.8%) | -$17.77M(-162.9%) |
Mar 2005 | - | $31.77M(-334.9%) | $28.26M(-222.4%) |
Dec 2004 | -$23.08M(-35.5%) | -$13.53M(+129.3%) | -$23.08M(-41.2%) |
Sep 2004 | - | -$5.90M(-137.1%) | -$39.27M(-256.8%) |
Jun 2004 | - | $15.91M(-181.3%) | $25.05M(-168.6%) |
Mar 2004 | - | -$19.57M(-34.1%) | -$36.55M(+2.1%) |
Dec 2003 | -$35.79M(-75.3%) | -$29.71M(-150.9%) | -$35.79M(-31.5%) |
Sep 2003 | - | $58.42M(-227.9%) | -$52.27M(-63.4%) |
Jun 2003 | - | -$45.69M(+142.9%) | -$142.87M(+6.9%) |
Mar 2003 | - | -$18.81M(-59.3%) | -$133.65M(-7.8%) |
Dec 2002 | -$144.89M(+121.1%) | -$46.20M(+43.6%) | -$144.89M(+21.8%) |
Sep 2002 | - | -$32.17M(-11.8%) | -$118.95M(+7.7%) |
Jun 2002 | - | -$36.47M(+21.3%) | -$110.44M(+29.1%) |
Mar 2002 | - | -$30.05M(+48.4%) | -$85.56M(+30.5%) |
Dec 2001 | -$65.54M(+90.5%) | -$20.25M(-14.4%) | -$65.54M(+30.5%) |
Sep 2001 | - | -$23.66M(+104.1%) | -$50.22M(+59.0%) |
Jun 2001 | - | -$11.59M(+15.4%) | -$31.59M(+21.1%) |
Mar 2001 | - | -$10.04M(+103.4%) | -$26.09M(-24.2%) |
Dec 2000 | -$34.41M(+79.2%) | -$4.93M(-1.8%) | -$34.41M(+49.8%) |
Sep 2000 | - | -$5.03M(-17.4%) | -$22.97M(-14.4%) |
Jun 2000 | - | -$6.08M(-66.9%) | -$26.84M(-4.7%) |
Mar 2000 | - | -$18.36M(-382.4%) | -$28.16M(+46.7%) |
Dec 1999 | -$19.20M(+45.5%) | $6.50M(-173.0%) | -$19.20M(-40.0%) |
Sep 1999 | - | -$8.90M(+20.3%) | -$32.00M(+58.4%) |
Jun 1999 | - | -$7.40M(-21.3%) | -$20.20M(+15.4%) |
Mar 1999 | - | -$9.40M(+49.2%) | -$17.50M(+32.6%) |
Dec 1998 | -$13.20M(+61.0%) | -$6.30M(-317.2%) | -$13.20M(+200.0%) |
Sep 1998 | - | $2.90M(-161.7%) | -$4.40M(-53.2%) |
Jun 1998 | - | -$4.70M(-7.8%) | -$9.40M(+8.0%) |
Mar 1998 | - | -$5.10M(-304.0%) | -$8.70M(+6.1%) |
Dec 1997 | -$8.20M(-71.6%) | $2.50M(-219.0%) | -$8.20M(-28.1%) |
Sep 1997 | - | -$2.10M(-47.5%) | -$11.40M(-32.1%) |
Jun 1997 | - | -$4.00M(-13.0%) | -$16.80M(-21.5%) |
Mar 1997 | - | -$4.60M(+557.1%) | -$21.40M(-26.0%) |
Dec 1996 | -$28.90M(+34.4%) | -$700.00K(-90.7%) | -$28.90M(+0.3%) |
Sep 1996 | - | -$7.50M(-12.8%) | -$28.80M(-12.7%) |
Jun 1996 | - | -$8.60M(-28.9%) | -$33.00M(+22.7%) |
Mar 1996 | - | -$12.10M(+1916.7%) | -$26.90M(+25.1%) |
Dec 1995 | -$21.50M(-21.5%) | -$600.00K(-94.9%) | -$21.50M(-32.4%) |
Sep 1995 | - | -$11.70M(+368.0%) | -$31.80M(+19.1%) |
Jun 1995 | - | -$2.50M(-62.7%) | -$26.70M(+36.2%) |
Mar 1995 | - | -$6.70M(-38.5%) | -$19.60M(-28.5%) |
Dec 1994 | -$27.40M(-32.0%) | -$10.90M(+65.2%) | -$27.40M(-18.5%) |
Sep 1994 | - | -$6.60M(-243.5%) | -$33.60M(-1.8%) |
Jun 1994 | - | $4.60M(-131.7%) | -$34.20M(-27.7%) |
Mar 1994 | - | -$14.50M(-15.2%) | -$47.30M(+17.4%) |
Dec 1993 | -$40.30M(+108.8%) | -$17.10M(+137.5%) | -$40.30M(-294.7%) |
Sep 1993 | - | -$7.20M(-15.3%) | $20.70M(-177.5%) |
Jun 1993 | - | -$8.50M(+13.3%) | -$26.70M(+15.6%) |
Mar 1993 | - | -$7.50M(-117.1%) | -$23.10M(+19.7%) |
Dec 1992 | -$19.30M(+147.4%) | $43.90M(-180.4%) | -$19.30M(-69.5%) |
Sep 1992 | - | -$54.60M(+1014.3%) | -$63.20M(+634.9%) |
Jun 1992 | - | -$4.90M(+32.4%) | -$8.60M(+132.4%) |
Mar 1992 | - | -$3.70M | -$3.70M |
Dec 1991 | -$7.80M | - | - |
FAQ
- What is Regeneron Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual FCF year-on-year change?
- What is Regeneron Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly FCF year-on-year change?
- What is Regeneron Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals TTM FCF year-on-year change?
What is Regeneron Pharmaceuticals annual free cash flow?
The current annual FCF of REGN is $3.54B
What is the all time high annual FCF for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual free cash flow is $6.53B
What is Regeneron Pharmaceuticals annual FCF year-on-year change?
Over the past year, REGN annual free cash flow has changed by -$128.70M (-3.51%)
What is Regeneron Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of REGN is $773.60M
What is the all time high quarterly FCF for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly free cash flow is $3.28B
What is Regeneron Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, REGN quarterly free cash flow has changed by -$577.10M (-42.73%)
What is Regeneron Pharmaceuticals TTM free cash flow?
The current TTM FCF of REGN is $2.96B
What is the all time high TTM FCF for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high TTM free cash flow is $7.94B
What is Regeneron Pharmaceuticals TTM FCF year-on-year change?
Over the past year, REGN TTM free cash flow has changed by -$968.00M (-24.63%)